Everest Medicines Announces Termination of Collaboration Agreements with Providence
- Written by PR Newswire
-Everest will continue to develop self-discovered products utilizing the mRNA platform-
SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines,...
Read more: Everest Medicines Announces Termination of Collaboration Agreements with Providence














